Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gum thickening breakthrough: your own blood may save your smile!

NCT ID NCT07521527

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, gentle way to thicken thin gums using a substance made from your own blood (called i-PRF). Thin gums can lead to gum recession and other problems. The treatment involves a few injections over time, and researchers will measure gum thickness with ultrasound for 6 months. It aims to improve gum health and appearance without major surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Systemically healthy individuals aged ≥18 years * Non-smokers or light smokers (≤10 cigarettes per day) * Individuals with full-mouth plaque score (FMPS) \<15% and full-mouth bleeding score (FMBS) \<15% * Individuals with gingival thickness \<0.8 mm in the mandibular anterior teeth to be treated * Periodontally healthy individuals with probing depth (PD) ≤3 mm in the mandibular anterior teeth * Absence of structural defects, crowns, or large restorations in the mandibular anterior teeth * Absence of missing or supernumerary teeth in the mandibular anterior region * No history of blood-borne infectious diseases * No systemic diseases or medical conditions Exclusion Criteria: * Individuals under 18 years of age * Pregnancy or breastfeeding * Presence of periodontal pockets \>4 mm * Presence of structural defects, crowns, or large restorations in the teeth * Presence of systemic diseases or coagulation disorders * Use of anticoagulant medications * Ongoing orthodontic treatment with active tooth movement * Use or history of medications affecting periodontal tissues (e.g., immunosuppressive drugs, calcium channel blockers, anticonvulsants) * History of periodontal surgery in the area to be treated

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Thin gingival biotype are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Çanakkale Onsekiz Mart University

    Çanakkale, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.